Abrdn PLC Relay Therapeutics, Inc. Transaction History
Abrdn PLC
- $51.7 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding RLAY
# of Institutions
207Shares Held
159MCall Options Held
100KPut Options Held
26.8K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$91.8 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$49.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$34.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.95MShares$29.4 Million3.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$26.5 Million2.5% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $396M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...